CLION - CAM Group, Altino Serbeto de Barros, 119 - 7th floor, Salvador, BA, 41830-907, Brazil.
Memorial Sloan Kettering Cancer Center, 300 East 66th Street - 8th floor, New York, NY, 10065, USA.
Curr Oncol Rep. 2018 Apr 11;20(6):47. doi: 10.1007/s11912-018-0688-8.
The rates of obesity are increasing worldwide and this condition is now recognized as a leading preventable cause of cancer. Several diseases are directly related to obesity, including diabetes, hypertension, atherosclerosis, stroke, musculoskeletal disorders, and a diverse range of malignances-such as breast cancer. Obesity is associated with an increased risk of postmenopausal estrogen receptor-positive breast cancer and worse cancer-related outcomes for all breast tumor subtypes. Several mechanisms have been proposed to contribute to the obesity-cancer link, including high levels of circulating and local estrogens, altered amounts of adipokines (leptin and adiponectin), disrupted insulin/IGF signaling, modifications within the microbiome, and local and systemic effects of inflammation. Here we will review recent advances in our understanding of the complex signaling pathways underlying the obesity-cancer link. An improved understanding of these processes is anticipated to propel novel and effective intervention strategies to reduce the global obesity-cancer burden.
全球肥胖率正在上升,这种情况现在被认为是癌症的主要可预防原因。几种疾病与肥胖直接相关,包括糖尿病、高血压、动脉粥样硬化、中风、肌肉骨骼疾病以及各种恶性肿瘤,如乳腺癌。肥胖与绝经后雌激素受体阳性乳腺癌的风险增加以及所有乳腺癌肿瘤亚型的癌症相关结局恶化相关。已经提出了几种机制来解释肥胖与癌症之间的联系,包括循环和局部雌激素水平升高、脂肪因子(瘦素和脂联素)的含量改变、胰岛素/IGF 信号转导中断、微生物组内的改变以及炎症的局部和全身影响。在这里,我们将回顾我们对肥胖与癌症之间联系的复杂信号通路的理解的最新进展。预计对这些过程的更好理解将推动新的有效的干预策略,以减轻全球肥胖和癌症负担。